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Opioid Substitution Therapy 
PWID 
a b s t r a c t 
Background: People who inject drugs (PWID) are a high-risk group for COVID-19 transmission and serious health 
consequences. Restrictions imposed in the UK in response to the pandemic led to rapid health and housing service 
alterations. We aimed to examine PWID experiences of: 1) challenges relating to the COVID-19 public health 
measures; 2) changes to opioid substitution therapy (OST) and harm reduction services; and 3) perceived effects 
of COVID-19 on drug use patterns and risk behaviour. 
Methods: Telephone semi-structured interviews were conducted with 28 PWID in Bristol, Southwest of England. 
Analysis followed a reflexive thematic analysis. 
Results: Concern about COVID-19 and adherence to public health guidance varied. Efforts made by services to 
continue providing support during the pandemic were appreciated and some changes were preferred, such as less 
frequent OST collection, relaxation of supervised consumption and needle and syringe programmes (NSP) home 
delivery. However, remote forms of contact were highlighted as less beneficial and more difficult to engage with 
than in-person contact. Public health guidance advising people to ‘stay home’ led to increased isolation, boredom, 
and time to ruminate which impacted negatively on mental health. Lockdown restrictions directly impacted on 
sources of income and routine. Changes in drug use were explained as a consequence of isolation and fewer 
interactions with peers, problems accessing drugs, reduced drug purity and reduced financial resources. 
Conclusion: This study captures the significant impacts and challenges of the COVID-19 pandemic on the lives 
of PWID. While rapid adaptations to service delivery to help mitigate the risks of COVID-19 were appreciated 
and some changes such as relaxation of supervised daily OST consumption were viewed positively, barriers to 
access need further attention. Going forwards there may be opportunities to harness the positive aspects of some 
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In the United Kingdom (UK) and worldwide, COVID-19 has resulted
n rapid and unprecedented changes to society, with public health mea-
ures to limit the spread of infection affecting housing services, health-
are systems, harm reduction and drug treatment provision ( Wisse et al.,
021 ). These changes are expected to have severe direct and indirect
mpacts on People Who Inject Drugs (PWID) ( Jacka et al., 2020 ), a pop-
lation often living unstable lives in a system of fragile state-provided
upport. 
PWID are considered at high risk of COVID-19 infection and more
evere health outcomes due to their susceptibility to infectious diseases,
nd cardiac and respiratory diseases ( Benzano et al., 2021 ; Jacka et al.,
020 ). Additional risks to PWID can be identified from a recent re-
iew of previous “Big Events ” (including natural disasters and heroin
hortages), which found these caused major disruptions to drug mar-
ets, negatively impacted participants’ mental health, and resultant eco-
omic instability affected the funding and coverage of harm reduction
nd treatment services ( Zolopa et al., 2021 ). COVID-19 public health
easures restricting social interactions to limit the spread of the virus
 Baker et al., 2021 ) are also anticipated to pose significant challenges
or PWID ( Jacka et al., 2020 ). For instance, purchasing and consum-
ng drugs represents a barrier to following public health guidance on
ocial distancing ( Jacka et al., 2020 ; Vasylyeva et al., 2020 ), increas-
ng risk of virus exposure and transmission. Border closures and re-
trictions of international movement leading to changes in drug sup-
ly may result in changes in the drugs used ( Chiappini et al., 2020 ;
asylyeva et al., 2020 ). PWID are already high-risk for mortality due
o overdose ( Bursztynsky, 2019 ), and rises in opioid overdose in San
rancisco (US) have been observed after social distancing was intro-
uced ( Rodda et al., 2020 ). Existing mental health and addiction is-
ues may also be amplified in this population due to the pandemic
 Zvolensky et al., 2020 ). 
These circumstances increase the need for harm reduction and
rug treatment, at a time when access to services may be reduced
 UNAIDS, 2020 ; Wisse et al., 2021 ). Needle and syringe programmes
NSP) reduce transmission of blood-borne viruses, and opioid substi-
ution therapy (OST) improves health outcomes ( Platt et al., 2017 ).
 recent review of suitable harm reduction interventions for PWID
uring circumstances such as global pandemics identified social dis-
ancing at NSP, and a flexible approach to OST are required to main-
ain harm reduction, alongside integration between harm reduction
roviders and providers of housing and healthcare ( Wilkinson et al.,
020 ). UK government guidance was developed for drug treatment ser-
ices ( Department of Health and Social Care, 2021 ), and services were
dvised to transfer most patients from daily supervised consumption to
ake home doses of OST and to lengthen prescriptions, as well as to max-
mise interventions to mitigate risk e.g. provision of take-home nalox-
ne. Recently, a need for researchers to collect data on patient experi-
nces during these unique changes to treatment has been highlighted
 Frank, 2021 ). 
The LUCID-B (Living Under Coronavirus and Injecting Drugs in Bris-
ol) study aimed to rapidly understand how the pandemic, public health
easures and associated changes to services were experienced to inform
uture emergency response. We specifically sought to explore how PWID
xperienced: 
1) Challenges relating to the COVID-19 public health measures; 
2) Changes to OST and harm reduction services; 
3) Perceived effects of COVID-19 and service delivery changes on drug
use patterns and risk behaviour. 
ethods 
LUCID-B was a rapid qualitative semi-structured telephone interview
tudy. 2 etting 
The study was conducted in Bristol, which has the highest age-
tandardised mortality rate for deaths related to drug use in the South-
est of England (7.6 per 100,000 in 2017-19) ( Office for National Statis-
ics, 2020 ). In Bristol, drug and alcohol services are delivered by Bristol
OADS (Recovery Orientated Alcohol and Drugs service), a partnership
etween Bristol Drugs Project, Developing Health and Independence
DHI) and Avon and Wiltshire Mental Health Partnership (AWP) NHS
rust. BDP are an independent agency offering a range of services for
eople who use drugs and alcohol including: BDP and pharmacy de-
ivered NSPs; shared care OST prescribing with GPs (care jointly pro-
ided by GP and BDP, with GPs taking responsibility for prescribing
nd monitoring, and BDP providing regular psychosocial input and sup-
ort through a shared care worker); a nurse led service for drug-related
hysical health issues; and mutual aid groups (see www.bdp.org.uk for
urther information). Other services used by PWID in the city include
 Homeless Health Service offering primary care and OST prescribing;
emporary accommodation including drug treatment hostels; an inpa-
ient detoxification unit; and mutual aid groups provided by DHI and
ther charitable organisations. 
Data were collected from 11 th June – 4 th August 2020. The first UK
ational lockdown was from 23 rd March – 4 th July; initially, legislation
rohibited the public from leaving home without a reasonable reason
nd closed all but essential businesses; from early June groups of up
o six could meet outside, retail businesses opened, and requirements
o wear face coverings began to be introduced; by August, two house-
olds could meet indoors, and pubs and restaurants opened ( Baker et al.,
021 ). Throughout this period, government guidance recommended so-
ial distancing measures ( Cabinet Office, 2021 ). On 17 th March govern-
ent funding for local authorities was announced for the ‘Everyone In’
cheme, which led to the rapid housing of people who were street home-
ess in commercial accommodation including hotels, to enable them
o self-isolate and prevent COVID-19 transmission ( Ministry of Hous-
ng, Communities and Local Government, 2020 ). 
Services for PWID in Bristol had to adapt in response to these public
ealth measures, mostly resulting in changes to form or route of delivery
ather than function ( Table 1 ). Essential face-to-face services (pharma-
ies and healthcare) continued with social distancing measures in place,
ut as far as possible interactions between service providers and service
sers (shared care OST and healthcare appointments) were conducted
emotely predominantly by telephone. Some mutual aid groups stopped,
ith others delivered online or by telephone; the inpatient detoxifica-
ion unit closed; and some pharmacy NSP services were withdrawn. Ef-
orts were made to commence as many PWID as possible on OST, re-
uirements for supervised consumption of OST were relaxed and service
sers were provided with up to two-weeks take-home supply. 
BDP re-deployed many of their staff into assertive outreach roles. The
DP NSP operated a doorstep service from its fixed site while a home
elivery NSP service was made widely available. OST was delivered to
linically vulnerable service users and an outreach service worked in
ublic areas and at homeless accommodation delivering NSP, nursing
are, hepatitis C testing and general psychosocial support. 
atient and public involvement 
Two people with lived experience of injecting drugs gave feedback
n our interview topic guide, our planned recruitment procedures and
ther study materials to ensure our questions and study information
ere appropriate. 
thics 
Ethical approval was provided by the Faculty of Health Sciences
ommittee for Research Ethics, University of Bristol (study ref no:
05042). 
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Table 1 
Service delivery changes under COVID-19. 
Service type Pre-pandemic Service changes 
General service provision • Most services delivered face to face. • Services provided remotely by telephone and online. 
• Access to some services affected by reduced opening times (at least 
initially), closure (residential rehabilitation, some groups and inpatient 
detoxification), initial lack of awareness of changes, lack of 
communication devices (no phone or internet access) and reluctance to 
discuss issues remotely or in less private spaces. 
Needle and syringe 
programmes (NSP) 
• Fixed site BDP NSP. 
• Fixed site community pharmacy NSPs. 
• Mobile harm reduction van serving areas on 
outskirts of Bristol. 
• BDP NSP delivered as doorstep service. BDP NSP doorstep service 
(people could attend BDP and wait outside, and a BDP team member 
would supply an NSP kit). 
• BDP home delivery NSP service made widely available. 
• Some community pharmacy NSPs closed, others had restricted opening 
times, problems with equipment supplies and long waiting times. 
• Scaled up outreach service offering NSP in public locations and 
temporary accommodation including commercial providers in the 
Everyone In scheme. 
Opioid Substitution 
Therapy 
• Prescribed by GP and BDP shared care service 
and Homeless Health Service. 
• Face to face appointments to commence/renew 
prescriptions and provide psychosocial support. 
• Collected from community pharmacies. 
• Rapid scripting service created. 
• Most shared care appointments over the telephone. 
• Some have requirement for supervised consumption relaxed and longer 
prescriptions issued with reduced frequency of medication collection. 
• BDP deliver prescriptions to clinically vulnerable. 
• Long waiting times in pharmacy 
Other drug treatment 
services 
• Multiple mutual aid groups provided by BDP 
and other organisations. 
• Residential rehabilitation services. 
• In patient detoxification unit. 
• Mutual aid groups initially suspended, with some delivered online or via 
telephone. 
• Rehabilitation services closed to new clients. 
• In patient detoxification unit closed. 
Health services • Primary care services provided by GP practices 
and Homeless Health Service. 
• BDP nurse-led physical healthcare service for 
people who use drugs. 
• Primary care appointments mostly conducted by telephone. 
• Continued provision of BDP nurse-led healthcare including hepatitis C in 
public spaces, particularly as part of the outreach service. 
Housing • Various homeless night shelters. 
• Temporary accommodation including drug 
treatment hostels. 
• Homeless night shelters closed. 
• Street homeless temporarily housed in commercial accommodation as 
part of Everyone In scheme. 
• Accommodation providers institute measures to reduce risk of 
transmission, with reduced face-to-face staff contact in many cases. 
Criminal justice service • “Activity days ” part of probation services 
usually conducted to benefit individual on 
probation 



















































c  ecruitment and sampling 
Participants were required to be at least 18 years old, English speak-
ng, and injecting drugs at the beginning of the national lockdown. 
BDP staff JW and DH identified participants who used their static
ervices or through their outreach work. The study was explained using
 participant information sheet and if consent was given their contact
etails were shared with the research team. A range of experiences were
aptured by purposefully recruiting through three routes (NSP home de-
ivery service, hotels/hostels part of the ‘Everyone In’ scheme, street out-
each) and inviting people with different demographic characteristics
age, gender, housing status) and drug treatment status. For example,
hose living in private accommodation were anticipated to face differ-
nt challenges than those offered accommodation during through the
Everyone In’ scheme. 
Because of the pandemic, it was necessary to conduct telephone
ather than face-to-face interviews to reduce the risk of COVID-19 trans-
ission. JK and AH conducted interviews during BDP outreach sessions
r at a pre-arranged time. Participants borrowed a telephone from BDP
orkers if necessary. The interviewer asked participants if they were in
 safe place where they could talk freely and confidentially and audio
ecorded verbal consent was taken. Participants received £10 cash as
hanks for their time. 
nterview topic guide 
Topics included demographic information, general experiences dur-
ng the pandemic, impacts on drug use, experience of service adaptations
nd responses to public health measures (see Supplementary Materials).3 he interview topic guide was applied flexibly and adapted to reflect the
hanging lockdown and data collected. 
pistemology 
The study was designed and undertaken implicitly assuming the core
enets of critical realism; that is, there is a perspective-independent re-
lity, but it is not possible to give an account of it devoid of perspec-
ive ( Maxwell, 2012 ). Accordingly, analysis involved reflection on both
he data itself and the perspectives of the researchers, aided by regu-
ar multidisciplinary team discussions (see acknowledgements for team
xpertise). 
This project was conducted with a multidisciplinary team. A core
roup of researchers (AH, HF, JK, JS, LH, MJL) - none of whom report
ived experience of injecting drugs - led the analysis with support from
he wider team including harm reduction experts delivering drug ser-
ices (DH, JW, MT, RA). 
ata analysis 
With informed consent, audio recordings were transcribed and
nonymised and an in-depth reflexive thematic analysis was undertaken
 Braun & Clarke, 2013 ). A combination of deductive coding, based on
he aims of the study and inductive coding, conducted for three tran-
cripts by JK in QSR NVivo, was applied. Each of these transcripts were
hen independently coded by a second researcher (AH, MJL, and LH)
o ensure each code was understandable; and to identify missing codes.
he purpose was to support the researchers to code the data not to assess
oding agreement. After discussion and further refinement, the coding













































































































ramework was applied to the rest of the transcripts by the researchers
JK, AH, HF, MJL, LH), with further codes added inductively. JK led the
ext stage of the process reviewing all the codes and coded data within
hem to identify patterns of similarity, creating ‘candidate themes’ and
 visual thematic map containing interconnected overarching themes,
hemes and sub-themes with a ‘central organising concept’ related to the
esearch aim and objectives. These candidate themes were discussed and
evised with the wider multidisciplinary research team by assessing how
ell they fit with the dataset, how they relate to each other and how
ell they address the overall research question before being finalised
 Braun & Clarke, 2013 ). During this process, some provisional candi-
ate themes were combined, divided or removed because they did not
rovide a coherent story of the data or address the research aim ( Braun
 Clarke, 2013 ). 
esults 
articipant characteristics 
Interviews lasting 20-56 minutes were conducted with 28 partici-
ants. For participant characteristics see Table 2 . There was no con-
istent pattern of change in drug use since the start of the pandemic;
articipants reported a range of behaviour from increases to reductions,
ncluding two who reported becoming abstinent. Two people attributed
heir own or another’s overdose during this period to polydrug use and
uctuations in drug supply. 
Findings are presented in three themes with supporting subthemes,
llustrated with anonymised verbatim quotes. The ‘Attitudes to COVID-
9’ theme captures concerns about COVID-19 and adherence to public
ealth measures. The ‘Sense of Support’ theme focuses on how people
elt their needs were met through their interactions with rapidly adapted
ervices. These ‘topic summary’ themes provide important contextual in-
ormation for the final theme ( Braun & Clarke, 2020 ): ‘Sense of Loss’.
his theme explores how for many, the pandemic exacerbated existing
ifficulties, highlighting absent things which could otherwise have im-
roved their lives. Considerations of how COVID-19 impacted drug use
atterns and risk behaviour run throughout the themes. 
ttitudes to COVID-19 
Some participants were not concerned about COVID-19 infection,
ith perceptions of low personal risk related to not knowing anyone
ho’d had it, not having many contacts with others anyway, taking
easures to prevent infection and awareness of low case numbers in
he Southwest of England. Others were not concerned, or were in de-
ial, about their risks of being infected; reasons for this included beliefs
bout immunity from previous infections such as the flu. A fatalistic
ttitude of COVID-19 being unavoidable was also expressed: 
I’m not, to be honest. I don’t know. No, it’s quite rare when you think
about it. It’s only one in a thousand people get it (…) To be honest, I
don’t personally know anyone who’s had it, so it’s not really affected me
that much. Interview 17, Male 
Interviewer: How concerned are you about it, about getting the
irus? 
Personally, I haven’t really been that concerned. I just think if you’re
gonna get it you’re gonna get it, if you’re not you’re not, if you’re gonna
die you’re gonna die, if you’re not you’re not. Interview 10, Male 
A backdrop of more pressing issues such as drug dependence and
ther health conditions explained a lack of concern about COVID-19
nd difficulties adhering to public health restrictions: 
I wake up unwell every morning and I’ve got to see the chemist for a start
(...) I was allowed to do that but then obviously (…) standing around
trying to earn your money and then getting your drugs is a lot of hours to
be out when you’re not supposed to be out at all. Interview 11, Female 4 While some had experienced symptoms of COVID-19 and a small
umber had self-isolated or been tested, it was noted that similar symp-
oms are common among people who inject drugs. Consequently, symp-
oms could be ascribed to other causes, explaining a lack of concern: 
When the virus first came about, I did have a bad chest but I have…
and a lot of people in here [temporary accommodation] do suffer with
symptoms that [laughs] do mimic Coronavirus. They cough a lot. We
have got bad chests from smoking drugs and… When you’re on heroin
you tend to sweat, hot and cold flushes, so I wouldn’t be surprised if there
had been a case of it and it had gone unnoticed. Interview 28, Female 
Conversely, COVID-19 infection concern related to perceived sus-
eptibility. For instance, one female participant explained “I was really
aranoid about it because I’ve got bad lungs anyway ” (Interview 16). Fur-
hermore, concerns related to exposure to peers and exposure to dealers
ot following public health guidance. Perceived severity of COVID-19
nfection, awareness of others infected with COVID-19 and the risk of
nfecting others heightened concern. 
There was good awareness of the lockdown and social distancing
uidelines obtained through the media and word-of-mouth. Many felt
ther people were not adhering to the guidance but they were doing
heir best to, describing increased hygiene measures, avoiding contact
ith others, wearing masks and gloves, and staying inside. 
Some people used drugs alone more due to lockdown restrictions and
concern about COVID-19, some were using more with others (due to
the need to pool limited resources to buy drugs) and others did not
change who they used with: 
Someone you could be using with could have that [COVID-19]. So, I was
using more on my own since that was about. Maybe sounds like keeping
myself safer but in the long run not ‘cause obviously if I’d gone over
[overdosed] there’d be no one there. Interview 9, Male 
Those forced to “break a few rules ” described instances of forgetting
o follow the guidelines due to intoxication and how the perpetual cycle
f earning money, buying and using drugs was a barrier to adherence.
or example, public drug deals were more difficult to conduct socially
istanced. While some dealers initially wore masks and gloves, others
ere perceived to be unphased by the pandemic and continued practices
ike carrying drugs in their mouths. 
When the lockdown started, it was very difficult being only allowed to go
out once a day for exercise. So, I was having to use that time to obviously
go and meet my dealer to get my drugs, or sometimes just hoping that I
wasn’t going to get stopped by the police and I’d go out and obviously if I
was to be stopped to say I was exercising. It did make things very difficult.
Interview 3, Male 
Participants who were concerned about contracting COVID-19 or
ere worried about breaking the lockdown restrictions found buying
rugs more difficult. Also, some dealers were reluctant to meet due to
ncreased visibility and concerns about COVID-19: 
A lot of the dealers obviously were scared to come out because they’d
stand out like a sore thumb, everything’s quiet and then they’re hanging
around. Interview 3, Male 
Living conditions in hostels were described as not conducive to social
istancing and rules against visitors were sometimes broken: 
The place that I live and the environment that I’m in it really would be like
fighting a losing battle. (…) I think it’s quite impossible for the residents,
yeah, definitely. With stairwells and they’re all down the corridor and it’s
all so compact in here, yeah. Interview 28, Female 
One suggestion was made for the instalment of handwashing facili-
ies in public spaces to support hygiene measures; especially during the
arly lockdown when shops and restaurants were closed. 
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Table 2 




NSP home delivery 9 
Fixed-site drug servce 4 












Street homeless 1 
Temporary: Homeless sleeping pod 1 
Temporary: Unspecified 1 
Temporary: Hotel 2 
Temporary: Hostel 10 
Temporary: Bedsit 1 
Temporary: Drug treatment hostel 4 
Council housing 3 
Living with family (parent) 2 




















Cocaine (powder) 2 
Diazepam 1 
Gabapentin 1 
Heroin (without crack cocaine) 7 










Reported changes to frequency, methods and types of drug use 3 
Drug administration change (e.g. smoking more/less, injecting more/less, 4 
Increased frequency 8 
Reduced frequency 8 
Variable frequency 3 
Stopped use 2 
No changes 1 
Change of drug 3 
Total 28 
5 


















































































































The narratives related to concern about COVID-19 and barriers to
adhering to public health measures highlight the importance of ap-
propriate communication methods and structural level mitigation
measures (such as the alterations in service provision described in
Table 2 ) which minimise risks while not placing sole responsibility
on individuals who may have significant competing issues to man-
age. 
ense of Support 
Participants appreciated the efforts made by services to continue pro-
iding support during the lockdown. Some service delivery adaptations
ere preferred and seen as improvements, while others were less well-
eceived but were viewed as “better than nothing ”. Many participants
id not suggest any improvements to services, believing providers were
oing as much as they could. This sense of enhanced support through
he ‘Everyone In’ scheme is illustrated in the following quote: 
There’s actually been bonuses to it [COVID-19] . Like I mean having more
attention from services and stuff. That’s how it’s felt, like they’ve cared
more about our welfare to a degree. So, I mean I was left sleeping under a
bridge for nine months and the moment the coronavirus happened it was
like ‘come on, come and get in a room’. Interview 22, female 
To some extent differences in how service adaptations were expe-
ienced, and overall experiences of the pandemic, can be attributed to
n individual’s pre-COVID-19 circumstances. Those with indicators of
reater stability and resources before the pandemic such as housing, in-
ome, health, drug use and treatment tended to be affected less (in some
ays), by the public health measures and experienced less pronounced
mpacts on drug use, than those with less stability. For some, the pan-
emic coincided with a critical point in their recovery, disrupting access
o the intensive support and connection with others in recovery provided
y residential detox services. For others with less stability in their lives
re-COVID-19, such as those experiencing homelessness, accounts re-
ect improvements in some aspects of support received although many
ulnerabilities were exacerbated. 
Enhanced outreach service provision ensured continued service ac-
ess and even improved access, convenience and support, while also
elping mitigate the risks of COVID-19. 
Rapid, proactively offered OST prescribing helped overcome reduced
rug access and supported self-isolation: 
Before COVID-19 it used to take a couple of weeks [to start a script] so
they did come through on that front by getting as many people scripted
as fast as they can [same day] so they could self-isolate if they need to.
Interview 27, Male 
Less frequent OST collection and relaxation of requirements for su-
ervised consumption in pharmacies were viewed favourably; exposing
ndividuals to drug using peers less, reducing stigma and embarrassment
hen publicly collecting medications and granting greater autonomy: 
I just don’t have to go to the chemist every day [relaxed OST collection
requirements] . (…) It’s less exposure. There’s always addicts and people
crawling around outside there. (…) It’s a form of control. Interview 13,
Male 
However, for one person daily OST collection was viewed positively
s it represented a reason to go out: 
It’s a lot easier and that, but in a way, I’ve been doing it for years, picking
up daily, so that was kind of my exercise in a way as well, getting out.
Interview 3, Male 
NSP delivered as a doorstep service (see Table 1 for description) at
DP, was viewed by some as a minimal change with little impact on will-
ngness to have open conversations with staff, due to good pre-existing
elationships. 6 In contrast to these forms of outreach and enhanced provision, for
hose using services which had to be travelled to, such as pharmacies,
educed opening times (at least initially) and social distancing limits
n the number of people allowed inside resulted in large queues and
ong waiting times for collection of OST and injecting equipment. There
ere also occasions when pharmacies ran out of equipment or stopped
unning their NSP which led to greater equipment re-use and sharing.
ome people attributed increased infections, abscesses, wounds, pain,
issing veins and swelling to equipment shortages as well as increased
rug use and poor drug quality/purity. Others did not perceive these
ssues to be any more prevalent than usual and a small number felt their
ealth was better. 
At first, we were using like four times we were using a pin four, five times
and it was hard to break through the skin because it was that blunt you
know what I mean. Because we’re in ((area 3.4 miles from Bristol Drugs
Project city centre NSP)) and ((location of Bristol Drugs Project)) is in
town. So, it was you know what I mean it was hard work. I’ve made a
right mess of my legs hence why I need the wound kits. Interview 2, Male
Queueing publicly outside busier than usual pharmacies to collect
ST was also disliked, caused anxiety and on some occasions meant
issed OST dispensing. 
NSP home delivery provided by BDP (see Table 1 ) for those stably
oused was viewed positively; it was convenient, discreet, required less
ffort and overcame barriers to accessing equipment in pharmacies. In-
reased outreach service provisions such as NSP home delivery was seen
o have reduced the risk of COVID-19 by limiting congregation, support-
ng self-isolation and removing exposure to peers for those attempting
o reduce their drug use. 
They’ve [NSP staff providing home delivery of injecting equipment]
been prompt, they’ve been accessible, they’re easy to talk to, they’re non-
judgemental, they try and get everything that you’ve ordered down. In-
terview 4, Female 
However, the public nature of NSP home delivery and doorstep NSP
t BDP restricted willingness to have open conversations. One female
articipant was also concerned about her daughter becoming aware of
er injecting due to the NSP home delivery: 
I want to get them [BDP NSP home delivery staff] as far away from her
[daughter] as possible, I don’t want her to know too much, you know?
(…) They gave some foil to me, because the last time they came, I come
into the house, she was downstairs and said ‘who’s that’? I was just like,
it’s [inaudible] oh yes, that’s for me, for foil. But she don’t know nothing
about the syringes I’ve got put away, they’re well hidden in my bedroom.
Interview 16, Female 
The ‘Everyone In’ scheme (see Table 1 ) was positively received,
hough the experience of living in the accommodation varied with noisy
nvironments at night-time and poor food reported. While some antici-
ated being offered longer-term housing and welcomed support from
ey workers, there was widespread concern caused by not knowing
hat support would be offered when the scheme ends. Communication
round this issue was not forthcoming and promises of support were not
lways realised. Indeed, one participant emphasised the scheme had not
olved the issue of homelessness: 
Homelessness is still a tangible problem because the government have ad-
dressed the actual pragmatic physical problem of putting a physical roof
over somebody’s head. It doesn’t address all the complex issues as to why
that person continually ends up back in the same situation over and over
again. Interview 13, Male 
For some, emergency accommodation shared with people who use
rugs encouraged use. 
In contrast, rules against using drugs in emergency accommodation
ere followed by some, meaning injecting outdoors or using less as this
articipant describes: 







































































































p  I used to use a lot with other people and now there’s not so many people
around me I’m not using much. Me and my missus would never get clean,
but now we’re in the hostel so we can lock ourselves away and ignore the
door and stay away from everyone. Interview 25, Male 
Others broke the rules and were concerned they might be evicted: I
ave been using in the hotel, but I worry about doing so. Interview 12, Male.
Drug-treatment housing continued to issue residents with warnings
nd punitive measures following positive drug test results despite a
eduction in support for substance use (e.g. residential group work
topped): 
They’ve [accommodation] still been giving the warnings out, even though
there hasn’t been the support here. Interview 19 
ense of Loss 
 loss of routine and income 
Guidelines to ‘Stay home’ disrupted patterns of daily life and resulted
n boredom which was the most common reason cited for increased drug
se: 
Boredom and a lot of the time because there’s nobody about; you’ve got
the money, there’s nobody to talk to, nothing to do, you’re just sitting
there piss bored and it’s like you know what? Fuck it, I’ll go and have a
little use and waste a few hours, you know what I mean? And then one
use is two, then three, then four and before you know it you’re back there
with a habit on your back. Interview 27, Male 
Although one person described their accommodation supplying ac-
ivity packs, there was a desire for more activities to structure the day,
specially in temporary housing: 
You get pissed off of being bored to be quite honest with you and doing
nothing. A big part of my day before was going out earning and scoring
and all that. Now I’m not doing that, sat about all the time watching TV
when I was in the hotel and there’s only so much nothing you can do. It
was doing my nut in. Interview 10, Male 
The lockdown directly impacted on sources of income which nega-
ively impacted on the ability to afford drugs. Two participants spoke of
icious cycles of being in debt to dealers. Job losses combined with no
ob opportunities, or being placed on the government’s furlough scheme,
mpacted on income and daily routine. Those reliant on mendicancy de-
cribed few people on the streets, with those who were around not carry-
ng cash as shops switched to only accepting contactless payments. The
ublic were “too scared ” to put money directly into the hands of those
sking for it and were reluctant to come near them due to distancing
uidance, which intensified felt stigma and dehumanisation: 
They make you feel like I’m a fucking disease. They won’t come near you
and they just chuck things at you. Before they just placed it in the hat
and probably stand and have a conversation with me but now they just
want to rush on by. Interview 23, Male 
First and second-hand accounts of committing and / or being a vic-
im of opportunistic theft, stealing from peers and reportedly increasing
evels of violence stemmed from difficulties accessing money. For exam-
le, shoplifting became difficult when non-essential shops closed and,
ueuing was necessary for entry and customer numbers were limited in
pen shops: 
People’s anonymity has gone because shoplifters have to queue up to
shoplift now, which has made violent and nasty crime. Interview 13,
Male 
I wasn’t on a script and I couldn’t beg so basically, I was walking down
the street and the streets were dead and I took a thing off the back of this
lorry but I did in right in front of the two cameras. Interview 25, Male 7 For some the inability to make money through usual means reflected
 positive change in relation to reduced drug use: 
Me and my partner [who had recently found out she was pregnant] well
she’s reduced [drug use] more than me but we’ve reduced drastically you
know what I mean? My life was chaos and I mean chaos, shoplifting four,
five times a day, supporting a £200 habit between two like so I’m doing
alright. Interview 2, Male 
Reduced financial resources and increased drug prices contributed
o reduced drug use, particularly for those already motivated to stop
re-pandemic. 
As soon as the virus come about my drug use plummeted to the point that
I stopped using for a little bit completely, for a couple of weeks (…). It
was hard to go out shoplifting; it was hard for me to go out and make
money and I decided to stop. In some senses the virus has helped me, it
sort of like cut my drug use right down. Interview 10, Male 
 loss of connection 
Lockdown measures led to isolation from friends and family (apart
rom co-habiting partners), and time to ruminate, all of which negatively
mpacted on mental health. For example, one female participant spoke
f not visiting her children and parents to protect her family: 
I haven’t seen my children. They live with my mum and dad over in ((city
nearby)). I have got the option to see them. I can see them whenever I
please but because of this virus I haven’t. I’ve chosen not to. I don’t want
to put them in any danger, not my family or my children. So, in that
aspect it’s been heart-breaking. Interview 28, Female 
For those with poor mental health, isolation caused by the lockdown
orsened symptoms: 
A lot of depression as well since this COVID-19 isolation. It ain’t very
good just sitting in your own mind all the time. Interview 20, male 
For people who struggle with mental health issues and addiction just being
n is the last thing you want because you end up getting less money and more
imes on drugs. (…) It’s obviously time to stew and reflect on things but also
ust the actual financial side of it like I lost my job and my flat I was in.
nterview 26, Male 
Others felt less affected by the isolation due to pre-COVID-19
arginalisation and seclusion 
There hasn’t really [been any change] for me personally because I basi-
cally live on the fringe of society anyway so the only people I really chat
to are the people that are willing to chat to me anyway so yes, it hasn’t
particularly made a massive difference to me. Interview 24, Female 
Enforced isolation and fewer interactions with peers combined with
roblems accessing drugs and reduced drug quality/purity including
uspicions drugs had been adulterated (e.g. fentanyl) contributed to re-
uced drug use, particularly for those already motivated to stop pre-
andemic. Other responses to impacts on drug supply included pooling
esources and sourcing drugs with others, stockpiling, travelling further
o meet dealers and changing to more readily available and cheaper
rugs including synthetic cannabinoids and one instance of changing
rom ketamine to heroin and crack. 
I used to do it more on my own and now obviously when it’s harder to
come by so if someone wants to get something you might put in together.
Interview 10, Male 
The lockdown also negatively affected connection in the form of
ommunication, initially resulting in a lack of awareness of service
hanges. Word-of-mouth communication between peers was more dif-
cult. Verbal and written information sharing about service alterations
ere vital. Many street-homeless or vulnerably housed people did not
ave phones or internet access to connect with services. For these peo-
le, there were feelings of being “out there blind ” and unable to access























































































































t  elp. A scheme to provide phones run by the charity St Mungo’s and the
omeless Health Service in Bristol was critical: 
They must have given out hundreds of these things, the cheap £10 phones.
A lot of people didn’t have a phone so they couldn’t have got any access to
anything without it because you can’t go and speak to the person because
of social distancing and if you’ve not got a phone or internet you’re not
getting to see or speak to that person. Interview 8, Female 
While for some participants switching to telephone OST appoint-
ents was easier due to reduced travelling, many accounts described
reater telephone and online contact as “just not the same ”. For exam-
le, one person expressed concern OST prescriptions would be stopped
f phone calls were missed. Remote contact was less beneficial, tiring,
mpersonal, difficult to know if the person was listening, and difficult to
penly discuss issues. Similarly, online drug support groups removed in-
ormal socialising and rituals around travel and took up less time in the
ay. The importance of connection in drug treatment and the disruption
o this caused by the pandemic is emphasised by this participant: 
They say the opposite of addiction is connection but how are you sup-
posed to connect with people when you’re not legally allowed to do that.
Interview 8, Female 
Concerningly, some perceived GP practices to be closed/inaccessible
nd others described less frequent appointments and more self-care: 
Where my doctors is, that’s all shut. (…) It shut temporarily during the
coronavirus. They’re only doing telephone appointments and stuff like
that, which is not the same thing. (…) I’ve spoken to them a couple of
times (…) but I haven’t actually spoken to the GP, no (…) you just get
the answer phone all day. Interview 13, Male 
reater visibility 
Previously private and hidden activities were made visible during
he lockdown. The streets being empty made scoring drugs discreetly
ifficult and being on the streets during this period was seen as tanta-
ount to being “up to no good ”: 
So, there’s a lot of people walking around to try and get drugs. Like you
all stand out like a sore thumb because you all look ill or rough or like
you’re using. Interview 21, Female 
Doorstep NSP removed privacy and anonymity; contributing to re-
uctance to access the service and have open conversations about drug-
elated issues. Concern was also expressed about arrests for drug pos-
ession due to visibility of the doorstep NSP: 
When I did walk past [Bristol Drugs Project] a few weeks ago and there
was a queue outside (…) it’s not usually a queue people would want to
be seen stood in. I don’t think people like that very much. Interview 28,
Female 
iscussion 
This study captures PWID experiences of the COVID-19 pandemic.
oncern about COVID-19 and perceptions of susceptibility and severity
aried. While many participants expressed intentions to follow social
istancing and lockdown measures, some found this difficult due to liv-
ng conditions and a perpetual cycle of earning money, buying and using
rugs. Impacts of public health measures and service delivery changes
ere less pronounced amongst those who possessed greater stability be-
ore the pandemic. Efforts made by services to continue providing sup-
ort during the pandemic were appreciated and some changes to harm
eduction services, such as less frequent OST collection, preferred. Im-
ortantly, remote forms of contact with services were unable to meet
ome people’s needs and preferences, and barriers to access were appar-
nt (e.g. lack of phones). Loss of routine and income and social support
orsened mental health problems and boredom due to “stay at home ”8 uidelines was cited as a reason for increasing drug use. In contrast, iso-
ation and fewer contacts with peers contributed to reduced drug use,
articularly for those motivated to stop before the pandemic. 
Key challenges relating to the COVID-19 public health measures
ere around feelings of loss, and low perceived personal risk from the
andemic, which intersected with factors specific to drug use and mental
ealth. Quantitative work amongst PWID suggests those with recent sub-
tance use are less likely to follow distancing measures ( Genberg et al.,
021 ). Barriers to following public health measures in this study, includ-
ng structural inequalities such as living conditions, are in line with find-
ngs that the most socially and economically disadvantaged face greater
bstacles to adherence ( Atchison et al., 2020 ; The Independent Scientific
dvisory Group for Emergencies, 2020 ). Risk to family members was a
eason to isolate from significant others; this social influence, and moral
bligation towards others were found to modestly predict intention to
ocially distance in an Australian survey, which tested an integrated so-
ial cognition model ( Hagger et al., 2020 ). Recent ethnographic research
f populations of PWID during COVID-19 has highlighted the impor-
ance of considering the dynamics of relatedness, isolation, and solitude
n experiences of both substance use and social distancing ( Roe et al.,
021 ). In combination with existing evidence, the present findings indi-
ate specific support may be required for PWID in maintaining connec-
ion and ensuring adherence to public health guidance. 
Changes in OST provision and assertive outreach were experi-
nced positively, but there were indications remote service provi-
ion and decreased privacy in service access may present barriers
or PWID. Work from Scotland has highlighted concerns regarding
nsupervised consumption, including pressures to divert medication
 Schofield et al., 2021 ), but as in recent quantitative work from the
S ( Figgatt et al., 2021 ) there were few reports of OST diversion in
he present study. In the North-West of England, COVID-19 restrictions
esulted in large reductions in NSP usage and the number of needles
istributed ( Whitfield et al., 2020 ), but this was not observed in our
ample. This may be due to rapid changes to assertive outreach and
SP home delivery, which were well received and cited as addressing
arriers to accessing equipment in pharmacies. These changes may have
educed accessibility issues which have emerged in recent North Amer-
can research ( Russell et al., 2021 ). Research from jurisdictions where
SP home delivery was not possible identified this as a barrier to treat-
ent access ( Seaman et al., 2021 ). However, as in other settings where
OVID-19 measures led to outdoor NSP provision ( Seaman et al., 2021 ),
here were some concerns about privacy. The move to provide drug and
ealth service consultations remotely was not universally well-received,
hich reflects findings from other groups with mental health issues dur-
ng COVID-19 ( Gillard et al., 2020 ). Services may wish to consider re-
ent innovations from providers in the US ( Tringale & Subica, 2021 ) to
vercome these issues. 
The public health measures and social disruption of the COVID-19
andemic impacted upon drug use, with instability, boredom and iso-
ation all identified as drivers of change; however, the extent to which
hese changes will sustain as public health measures ease is unknown.
ther UK and Canadian studies observed COVID-19 measures influenced
rug use ( Ali et al., 2021 ; Croxford et al., 2021 ; Public Health Eng-
and, 2020 ; Public Health England et al., 2020 ; Schofield et al., 2021 ;
cott et al., 2020 ), and in the US COVID-19 related stressors were linked
o relapse ( Hurley et al., 2021 ). Consequently, the issues with supply
nd changes in substance use during COVID-19 appear to have affected
WID globally. Although there was limited reporting of overdose in the
resent study, decreases in drug use are likely to be accompanied by re-
ultant changes in tolerance. There is a need to consider these changes
n relation to the drug-risk environment, which Grebely and colleagues
ighlighted may be worsened by COVID-19 (e.g. neighbourhood depri-
ation, cost of living, lack of employment opportunities) ( Grebely et al.,
020 ). As policy makers and service providers reflect on the potential
mpacts of COVID-19 adaptations, it will be important to consider how
o minimise the effects of an increasingly high risk environment amongst













































































































 population which has undergone rapid shifts in their drug use be-
aviours. 
This study highlighted the need to support PWID holistically with
oined-up strategic cooperation amongst local service providers, ad-
ressing reduced income, housing access, difficulty managing mental
ealth and support for drug use; this is in line with recent recommen-
ations for drug policy in the UK ( Black, 2021 ). The pandemic could be
een as a ‘window of opportunity’ to rethink policy and practice, with
ome impacts viewed as positive by PWID (e.g. changes to OST provi-
ion) ( Wisse et al., 2021 ). For example, decision-making about contin-
ing changes made to OST prescribing should be informed by evidence
hese changes are viewed positively by service users. More research is
equired to explore the effect of recent changes on treatment outcomes
nd mortality to inform policy decisions. If changes to remote service
elivery through telecommunications are maintained, it will be impor-
ant to ensure PWID are not digitally excluded. 
imitations 
Our recruitment approach means the sample may not reflect the
iews of those who are most disengaged from services and potentially
n greatest need. However, recruitment via outreach is expected to have
eached beyond those who usually access drug services – as evidence
y some participants being unknown to the drug service recruiters. Be-
ond asking participants if they were in a safe and confidential space
hey were happy to talk to us in, we could not guarantee whether or
ot parts of the interview would be audible to anyone in the vicinity of
he interviewee. Although we involved PWID in the design and set up
f the study, a limitation is we did not involve PWID in the analysis or
nterpretation of the study findings. 
onclusion 
The COVID-19 pandemic presented significant challenges for PWID
n relation to service access and loss of connection and routine. Rapid
daptations to service delivery aiming to help mitigate the risks of
OVID-19 infections, were appreciated and some changes such as re-
axation of supervised daily OST consumption were viewed positively.
owever, those facing the greatest barriers to remote service provision
t a time of heightened isolation and loss of routine may require tailored,
ore intensive support. 
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